Osteoporosis Powerpoint

download Osteoporosis Powerpoint

of 45

Transcript of Osteoporosis Powerpoint

  • 8/9/2019 Osteoporosis Powerpoint

    1/45

    Osteoporosis?

  • 8/9/2019 Osteoporosis Powerpoint

    2/45

  • 8/9/2019 Osteoporosis Powerpoint

    3/45

  • 8/9/2019 Osteoporosis Powerpoint

    4/45

    %re&uency

    Appro'imately 10 million peoplehave osteoporosis. Another 1(#1)million have osteopenia *low bone

    mass+

    Appro'imately 1. million !ractures peryear in the nited -tates are attributed to

    osteoporosis, and more than 3,000people die !rom subse&uent !racture#

    related complications

  • 8/9/2019 Osteoporosis Powerpoint

    5/45

    /omen vs. Men

    • egin bone loss intheir (0s

    • apid loss o! bone

    mass !or #10 yearsa!ter menopauseonset

    • -maller bone cortices

    and diameter !romgrowth phase,especially duringpuberty

    • egin bone loss intheir (0s

    • one loss remainslinear and slow as

    se' steroidproductionprogressivelydeclines

    • 2arger bonecortices anddiameter !rom

    growth phase

  • 8/9/2019 Osteoporosis Powerpoint

    6/45

    Other is %actors

    • hronic glucocorticoid e'cess• 4yperthyroidism

    • 5nappropriately high 64 

    replacement

    • Alcoholism

    • $rolonged immobili7ation

    • 8astrointestinal disorders

    • 4ypercalciuria• Malignancies

    • igarette smoing

  • 8/9/2019 Osteoporosis Powerpoint

    7/45

    Medical onditions Associated with5ncreased is o! Osteoporosis

    • O$9

    • ushing:s syndrome

    • ;ating disorders

    • 4yperparathyroidism

    • 4ypophosphatasia

    • 5-

    • A, otherautoimmuneconnective tissuedisorders

    • 5nsulin dependentdiabetes

    • Multiple sclerosis

    • Multiple myeloma

    • -troe *

  • 8/9/2019 Osteoporosis Powerpoint

    8/45

    9rugs Associated witheduced one Mass

    • Aluminum

    • Anticonvulsants

    • ytoto'ic drugs

    • 8lucocorticosteroids*oral=high doseinhaled+

    • 5mmunosuppresants

    • 8onadotropin#releasing hormone*e.g. 2upron+

    • 2ithium

    • 4eparin *chronic use+• -upraphysiologic

    thyro'ine doses

    • Aromatase inhibitors

    • 9epo#$rovera

  • 8/9/2019 Osteoporosis Powerpoint

    9/45

    Anatomy 6he -eletal-ystem

    • %unctions o! the -eletal-ystem – -upport against gravity

     – 2everage !or muscle action #movement

     – $rotection o! so!t internal

    organs – lood cell production

     – -torage # calcium,phosphorous, !at

  • 8/9/2019 Osteoporosis Powerpoint

    10/45

     6he -eletal -ystem

    •  6he seletal system includes> – ones

     – artilages – ?oints

     – 2igaments

     – Other connective tissues

  • 8/9/2019 Osteoporosis Powerpoint

    11/45

    8eneral -hapes O! ones – 2ong bones *e.g., humerus, !emur+

     – -hort bones *e.g., carpals, tarsals, patella – %lat bones *e.g., parietal bone, scapula, sternum+

     – 5rregular bones *e.g., vertebrae, hip bones+

  • 8/9/2019 Osteoporosis Powerpoint

    12/45

    -tructure o! 6ypical 2ong one• 9iaphysis # tubular sha!t !orming

    the a'is o! long bones. –  omposed o! compact bone

     –  entral medullary cavity

     –  ontains bone marrow

    • ;piphysis @ e'panded end o! long

    bones. – omposed mostly o! spongy bone

     –  ?oint sur!ace is covered with articular(hyaline) cartilage

     – ;piphyseal lines separate thediaphysis !rom the epiphyses

    • Metaphysis @ where epiphysis anddiaphysis meet

  • 8/9/2019 Osteoporosis Powerpoint

    13/45

    one Membranes• $eriosteum

     – $rovides anchoring points !ortendons and ligaments

     – 9ouble#layered protectivemembrane, supplied withnerve fbers, blood, andlymphatic vessels enteringthe bone via nutrient!oramina.

     – 5nner osteogenic layer iscomposed o! osteoblasts andosteoclasts

    • ;ndosteum

     – 9elicate 6 membranecovering internal sur!aces o!bone

     – overs trabeculae o! spongybone

     – 2ines canals in compact bone

     – Also contains bothosteoblasts and osteoclasts

  • 8/9/2019 Osteoporosis Powerpoint

    14/45

    ells in one

    • Osteoprogenitor cells @ precursors toosteoblasts

    • Osteocytes # mature bone cells betweenlamellae

    • Osteoclasts # bone#destroying cells, breadown bone matri' !or remodeling and releaseo! calcium – -ource o! acid, en7ymes !or osteolysis

     – alcium homeostasis• Osteoblasts # bone#!orming cells

     – esponsible !or osteogenesis *new bone+

     – -ource o! collagen, calcium salts

  • 8/9/2019 Osteoporosis Powerpoint

    15/45

    one #emodeling=4omeostasis

    • ole o! emodeling in -upport – emodelingontinuous breadown and

    re!orming o! bone tissue

     – -hapes reBect applied loads

     – Mineral turnover enables adapting to newstresses

    • /hat you don:t use, you lose. 6he

    stresses applied to bones duringe'ercise are essential to maintainingbone strength and bone mass

  • 8/9/2019 Osteoporosis Powerpoint

    16/45

    one emodeling

    • one is active tissue @ small changes in bone

    architecture occur continuously @ to C o! bonemass is recycled weely @ spongy bone is replacedevery 3#( years and compact bone appro'imatelyevery 10 years

    • emodeling nits @ adDacent osteoblasts andosteoclasts deposit and reabsorb bone at periostealand endosteal sur!aces

  • 8/9/2019 Osteoporosis Powerpoint

    17/45

    one emodeling

    • one 9epostition

     – Occurs when bone is inDured or e'tra strength is needed – e&uires a healthy diet # protein, vitamins , 9, and A,

    and minerals *calcium, phosphorus, magnesium,manganese, etc.+

    • one esorption

     – Accomplished by Osteoclasts *multinucleate phagocyticcells+

     – esorption involves osteoclast secretion o!>

    • 2ysosomal en7ymes that digest organic matri'

    • 4l that converts calcium salts into soluble !orms

     – 9issolved matri' is endocytosed and transcytosed intothe interstitial Buid E the blood

  • 8/9/2019 Osteoporosis Powerpoint

    18/45

    $athophysiology

    • alance between bone resorptionand !ormation *remodeling+ – emodeling is in balance until about age

    0• Osteoclasts resorb bone

    • Osteoblasts !orm bone

    • ;strogen inhibits osteoclastic boneresorption

    • $ea bone mass is established by

    age F0 !or the hip and during the:

  • 8/9/2019 Osteoporosis Powerpoint

    19/45

    $athophysiology

    • /omen have increased incidence o!osteoporosis compared to men due to>

     – 2ower pea bone mass

     – 8reater bone loss a!ter menopause *10Cbone loss+

    • Men and non#white women have higherpea bone mass than white women

    • 8enetic !actors @ 0#)0C o! pea bonemass is genetically determined

    • $regnancy and lactation cause transient

    bone loss

  • 8/9/2019 Osteoporosis Powerpoint

    20/45

    $athophysiology

    • one &uality – 9isruption o! microarchitectural

    elements o! trabecular bone

     – ortical thinning

     – 9ecrease in degree o! minerali7ation

  • 8/9/2019 Osteoporosis Powerpoint

    21/45

    one Mineral 9ensity 6esting

    So Who Do We Test?

    • $ostmenopausal women older than G years

    • $ostmenopausal women younger than G years whohave 1 or more ris !actor

    • $ostmenopausal women who present with !ragility!ractures

    • /omen who are considering therapy in which M9will aHect that decision

    • /omen who have been on hormone replacement

    therapy *46+ !or prolonged periods• Men who e'perience !ractures a!ter minimal trauma

    • $eople with evidence o! osteopenia on radiographs ora disease nown to place them at ris !or osteoporosis

  • 8/9/2019 Osteoporosis Powerpoint

    22/45

    2ab -tudies

    • 2evels o! serum calcium, phosphate,and alaline phosphatase are usuallynormal in persons with primary

    osteoporosis, although alalinephosphatase levels may be elevated!or several months a!ter a !racture

    • 5t is important to also chec thyroid!unction, and testosterone levels inmen

  • 8/9/2019 Osteoporosis Powerpoint

    23/45

    M9 5maging

    • M9 tests are usually done on bonesthat are liely to brea as a result o!osteoporosis lie the lower spine and

    hip• an also be done on the wrist or heel

    • 9evices that measure M9 include>

     – Iuantitative computed tomography – 9ual#energy '#ray absorptiometry

    *9;JA+

     – Iuantitative ultrasonography

     – adiogrammetry

  • 8/9/2019 Osteoporosis Powerpoint

    24/45

    Iuantitative omputed 6omography

    • Iuantitative computed tomographymeasures M9 as a true volume density ing=cm3, which is not inBuenced by bonesi7e.

    •  6his techni&ue can be used !or both adultsand children.

    • 9isadvantages in that *1+ it only

    determines bone density at the spine, *F+osteophytes can inter!ere withmeasurement, and *3+ it is associated withsignifcant radiation e'posure and highcost

  • 8/9/2019 Osteoporosis Powerpoint

    25/45

    9;JA

    • 9ual#energy '#ray absorptiometry re&uires lessradiation, is less e'pensive, and has betterreproducibility than &uantitative computedtomography

    • an also measure bone density at the spine andthe hip. 5t has become the standard method !ordetermining bone density.

    •  6his method can be used in both adults andchildren

    • on!ounding !actors in 9;JA resultsinterpretation *!alsely high bone density+ includespinal !ractures, osteophytosis, and e'traspinal*eg, vascular+ calcifcation

    • $eripheral 9;JA can be used to measure M9 inthe wrist

  • 8/9/2019 Osteoporosis Powerpoint

    26/45

    Iuantitativeltrasonography

    • Iuantitative ultrasonography o! thecalcaneus can be used !or generalscreening

    • 4owever, this is not as accurate asother methods and thus is less use!ulin !ollowing response to treatment

    • 5ts advantages include low cost,portability, and lac o! ioni7ingradiation

  • 8/9/2019 Osteoporosis Powerpoint

    27/45

    adiogrammetry

    • adiogrammetry, used to measurecortical dimensions, is usuallyper!ormed on the hand, specifcally

    the second metacarpal• 5t is use!ul in assessing M9 in

    children and is the simplest and leaste'pensive method

    • 9isadvantages are that it is not asprecise as 9;JA and, there!ore, isless sensitive !or detecting changes

    over time

  • 8/9/2019 Osteoporosis Powerpoint

    28/45

    /hat Are 6he esultsK

    • esults are reported as two values, 6 andL scores

    •  6 scores are the number o! standard

    deviations above or below what isnormally e'pected in a healthy youngadult o! the same se'

    • L score is the number o! standard

    deviations above or below what isnormally e'pected !or someone o! thesame age, se', weight, and ethinic origin

  • 8/9/2019 Osteoporosis Powerpoint

    29/45

     6 -core

    • Above #1 indicates the bone densityis normal

    • etween #1 and #F. indicates bonedensity is below normal, orosteopenia

    • elow #F. indicates osteoporosis

  • 8/9/2019 Osteoporosis Powerpoint

    30/45

    9;JA 5mages

  • 8/9/2019 Osteoporosis Powerpoint

    31/45

    M9 -core eport

  • 8/9/2019 Osteoporosis Powerpoint

    32/45

    L -core

    •  6he L score is help !ul because itmay suggest that the patient mayhave a secondary !orm o!

    osteoporosis unrelated to normalaging which is causing decreasedM9

    • A score less than #1. should maeyou investigate the cause o!decreased M9

  • 8/9/2019 Osteoporosis Powerpoint

    33/45

    Another eport ard

    • %or e'ample, i! the 6#score is #F.0, the M9 islower than average by two standard deviations. 5!the L#score is #0., your bone density is less thanthe norm !or people your age by one#hal! o! a

    standard deviation 

  • 8/9/2019 Osteoporosis Powerpoint

    34/45

    I6

  • 8/9/2019 Osteoporosis Powerpoint

    35/45

    I6

    • I6 isolates metabolically activetrabecular bone !or greater anatomicaccuracy than other methods

    • A series o! a'ial scans are taen withthe patient lying on a calibrationphantom

  • 8/9/2019 Osteoporosis Powerpoint

    36/45

    Other 6ests

    • As mentioned earlier, ultrasound andradiogrammetry can be used as well

    •  6hese are not as accurate indetermining M9 loss but haveadvantages lie less radiation,smaller e&uipment, and they

    measure M9 using smaller bones

  • 8/9/2019 Osteoporosis Powerpoint

    37/45

     6reatment

    Universal Recommendations :

    • Ade&uate intae o! calcium, vitamin 9

    • /eight#bearing and muscle#strengthening e'ercisesto reduce ris o! !alls=!racture

    • $rovide strategies !or !all prevention

    • Avoidance o! tobacco use=e'cessive alcohol use

    •  6al to your provider about bone health

    • 4ave a bone density test and tae medication whenappropriate

  • 8/9/2019 Osteoporosis Powerpoint

    38/45

    Ade&uate 5ntae o! alcium=

  • 8/9/2019 Osteoporosis Powerpoint

    39/45

    alcium=9 $roduct-election

    $roduct *Celemental a+

    ;lemental

    alcium*mg+

  • 8/9/2019 Osteoporosis Powerpoint

    40/45

    0,000 5 vit9 weely ' G#) wees, thenassess need !or chronic monthly therapy

    l / i ht i

  • 8/9/2019 Osteoporosis Powerpoint

    41/45

    egular /eight#earing;'ercise

    • 9efned as those in which bones andmuscles wor against gravity as !eet andlegs bear the body:s weight

    • 5nclude waling, Dogging, 6ai#hi, stairclimbing, dancing, tennis, yoga

    • 5mprove agility, strength, balance

    • May increase bone density modestly,reduce !all ris, enhance muscle strength,improve balance

  • 8/9/2019 Osteoporosis Powerpoint

    42/45

    Avoidance o! 6obacco and Alcohol

    •  6obacco products detrimental toseleton, overall health

    • PO% strongly encourages tobaccocessation programs as osteoporosisintervention

    • ;'cessive alcohol intae alsodetrimental to bone health andre&uires treatment

  • 8/9/2019 Osteoporosis Powerpoint

    43/45

    /ho -hould e 6reatedKNOF Recommendations – 2008

    • 5nitiate therapy to reduce !ractures inpostmenopausal women=men 0with>

    1. M9 6#scores Q #F. at hip or spineF. $rior vertebral or hip !racture

    3. 2ow bone mass *6#scores #1.0 to #F. at

    hip or spine+ when> – 10#year probability o! hip !racture is 3C – 10#year probability o! maDor osteoporosis#

    related !racture is F0C

     – ased on -#adapted /4O algorithmwww.nof.org

  • 8/9/2019 Osteoporosis Powerpoint

    44/45

    %9A#Approved 9rugs !or Osteoporosis

    • isphosphonates – Alendronate,

    Alendronate plus 9*%osama'R, %osama'$lus 9R+

     – isedronate,isedronate withalcium *ActonelR+

     – 5bandronate *onivaR+

    • -elective ;strogen

    eceptor Modulators *-;Ms+ – alo'i!ene *;vistaR+

    • alcitonin *MiacalcinR,%orticalR, alcimarR+

    • $arathyroid 4ormone 

    S$64 *1#3(+,teriparatideT – %orteoR

    • ;strogen=4ormone

     6herapy *;6=46+ – $remarinR, ;straceR,

    $remproR

  • 8/9/2019 Osteoporosis Powerpoint

    45/45

    9a!tar $ustaa

    • ==www.webmd.com=osteoporosis=ss=slideshow#osteoporosis#overviewV 9iases ?anuari F01(.

    • auer, 9. se o! statins and !racture> results o! (prospective studies and cumulative meta#analysis o!observational studies and controlled trials. Arch 5nternMed. F00( ?an.

    • 9empster 9/, et al.  J Bone Miner Res. 1W)G>1>1#F1Xeprinted with permission !rom the American -ociety o!one and Mineral esearch.

    • AA; 8uidelines !or 9iag and 6reatment o! Osteoporosis #F010

    http://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/osteoporosis/ss/slideshow-osteoporosis-overviewhttp://www.webmd.com/osteoporosis/ss/slideshow-osteoporosis-overviewhttp://www.webmd.com/osteoporosis/ss/slideshow-osteoporosis-overviewhttp://www.webmd.com/osteoporosis/ss/slideshow-osteoporosis-overviewhttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnadahttp://www.webmd.com/karriem-norwood-varnada